|
For the three months ended |
For the years ended |
||||
|---|---|---|---|---|---|
|
(In millions of canadian dollars, except per share amounts or as otherwise noted) |
Sept. 30 |
June 30 |
Sept. 30 |
Dec. 31 |
Dec. 31 |
|
Revenues(1)(2) |
15,422 |
3,824 |
12,972 |
48,098 |
51,362 |
|
Net earnings attributable to participating shareholders |
359 |
278 |
186 |
1,287 |
1,286 |
|
Net earnings per participating share |
0.84 |
0.64 |
0.40 |
2.77 |
2.77 |
|
Adjusted net earnings attributable to participating shareholders(3) |
332 |
372 |
283 |
1,438 |
1,560 |
|
Adjusted net earnings per participating share(3) |
0.78 |
0.86 |
0.61 |
3.09 |
3.36 |
|
Dividends declared per participating share |
0.4050 |
0.4050 |
0.3820 |
1.5045 |
1.4105 |
|
Consolidated assets |
472,204 |
467,390 |
453,710 |
452,303 |
445,521 |
|
Shareholders' equity |
13,893 |
13,802 |
14,966 |
15,118 |
14,615 |
|
Book value per participating share |
30.34 |
30.18 |
30.06 |
30.38 |
29.40 |
|
Participating shares outstanding (in millions) |
426.2 |
425.5 |
465.9 |
466.0 |
464.3 |
(1) Comparative figures for 2017 have been adjusted as a result of IFRS 15 as described in Note 2 to the Corporation's December 31, 2018 consolidated financial statements.
(2) The decrease in revenues in the second quarter of 2019 is due to the impact of Lifeco's sale, via indemnity reinsurance, of its U.S. individual life insurance and annuity business to Protective Life (initial reinsurance ceded premiums of $13.9 billion).
(3) Adjusted net earnings attribuable to common shareholders and adjusted net earnings per common share are non-IFRS financial measures. Refer to the "Non-IFRS Financial Measures and Presentation" section of the Corporation's most recent Management's Discussion and Analysis for the definition of non-IFRS financial measures and their reconciliation with IFRS financial measures.
|
As at and for the years ended December 31 [in millions of Canadian dollars, except as otherwise noted] |
2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
|
Consolidated Balance Sheets |
|||||
|
Cash and cash equivalents |
6,441 |
5,903 | 5,182 | 5,085 |
4,431 |
|
Total assets |
452,303 |
445,521 | 422,724 | 422,859 |
377,781 |
|
Shareholders’ equity |
15,118 |
14,615 | 13,864 | 13,978 |
11,931 |
|
Consolidated Statements of Earnings |
|||||
|
Revenues |
|||||
|
Premium income, net(1) |
35,440 |
33,880 | 31,125 | 24,501 |
21,222 |
|
Net investment income |
3,069 |
8,074 | 10,335 | 4,869 |
13,706 |
|
Fee income(1) |
8,776 |
8,510 | 7,794 | 7,692 |
6,990 |
| Other revenues |
813 |
898 | 1,496 | 1,203 |
711 |
| Total revenues |
48,098 |
51,362 | 50,750 | 38,265 |
42,629 |
|
Expenses |
|||||
|
Total paid or credited to policyholders |
32,068 |
35,643 | 34,675 | 22,842 |
29,160 |
|
Commissions(1) |
3,512 |
3,712 | 3,590 | 3,133 |
2,901 |
|
Operating and administrative expenses(1) |
8,175 |
8,132 | 8,023 | 7,239 |
6,066 |
|
Financing charges |
462 |
512 | 490 | 480 |
457 |
|
Total expenses |
44,217 |
47,999 | 46,778 | 33,694 |
38,584 |
|
Earnings before investments in jointly controlled corporations and associates, and income taxes |
3,881 |
3,363 | 3,972 | 4,571 |
4,045 |
|
Share of earnings (losses) of investments in jointly controlled corporations and associates |
164 |
214 | (122) | 213 |
215 |
|
Earnings before income taxes |
4,045 |
3,577 | 3,850 | 4,784 |
4,260 |
|
Income taxes |
578 |
543 | 587 | 685 |
824 |
|
Net earnings |
3,467 |
3,034 | 3,263 | 4,099 |
3,436 |
|
Attributable to |
|||||
|
Non-controlling interests |
2,128 |
1,696 | 2,129 | 2,261 |
2,109 |
|
Non-participating shareholders |
52 |
52 | 52 | 52 |
52 |
|
Participating shareholders |
1,287 |
1,286 | 1,082 | 1,786 |
1,275 |
|
3,467 |
3,034 | 3,263 | 4,099 |
3,436 |
|
|
Per share |
|||||
|
Net earnings attributable to participating shareholders |
2.77 |
2.77 | 2.33 | 3.86 |
2.77 |
|
Adjusted net earnings attributable to participating shareholders(2) |
3.09 |
3.36 | 2.64 | 3.40 |
2.69 |
|
Dividends declared on participating shares |
1.50 |
1.41 | 1.32 | 1.22 |
1.16 |
|
Book value per participating share |
30.38 |
29.40 | 27.84 | 28.08 |
23.74 |
|
Market price (Participating shares) |
|||||
|
High |
32.56 |
33.68 | 31.03 | 34.57 |
32.87 |
|
Low |
23.57 |
28.65 | 26.77 | 27.15 |
27.60 |
|
Year-end |
24.53 |
32.37 | 30.05 | 28.94 |
31.76 |
(1) Comparative figures for 2017 have been adjusted as a result of IFRS 15 as described in Note 2 to the Corporation's December 31, 2018 consolidated financial statements.
(2) Adjusted net earnings attribuable to participating shareholders per share is a non-IFRS financial measure. Refer to the "Non-IFRS Financial Measures and Presentation" section of the Corporation's most recent Management's Discussion and Analysis for the definition of non-IFRS financial measures and their reconciliation with IFRS financial measures.
